Skip to content
Accessibility help
Search NICE…
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Deferred
Awaiting development
Topic prioritisation
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
Type
Guidance (7)
Guidance programme
Guidance programme
Technology appraisal guidance (7)
Apply filters
Showing 1 to 7 of 7
Sort by
Date
Title
Apply sorting
Keyword or reference number: Cabozantinib
`Remove $Keyword or reference number: Cabozantinib filter`
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Cabozantinib
with nivolumab for untreated advanced renal cell carcinoma
TA964
10 April 2024
10 April 2024
Cabozantinib
for previously treated advanced differentiated thyroid cancer unsuitable for or refractory to radioactive iodine
TA928
1 November 2023
1 November 2023
Cabozantinib
for previously treated advanced hepatocellular carcinoma
TA849
14 December 2022
14 December 2022
Nivolumab with
cabozantinib
for untreated advanced renal cell carcinoma (terminated appraisal)
TA785
20 April 2022
20 April 2022
Cabozantinib
for untreated advanced renal cell carcinoma
TA542
3 October 2018
3 October 2018
Cabozantinib
for treating medullary thyroid cancer
TA516
28 March 2018
28 March 2018
Cabozantinib
for previously treated advanced renal cell carcinoma
TA463
9 August 2017
9 August 2017
Current page
1
Page
1
of
1
Results per page
10
25
50
All
Back to top